Vascular permeability factor vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation

被引:88
作者
Watanabe, Y
Dvorak, HF
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02215
[2] TOKYO INST TECHNOL,DEPT BIOMOL ENGN,MIDORI KU,YOKOHAMA,KANAGAWA 226,JAPAN
关键词
D O I
10.1006/excr.1997.3583
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survival and proliferation of endothelial cells requires both growth factors and an appropriate extracellular matrix tip which cells can attach, In the absence of either, endothelial cells rapidly undergo apoptosis. Thus, when human microvascular endothelial cells (HDMEC) are plated on a hydrophobic surface such as untreated polystyrene, they rapidly undergo apoptosis and die, The present study demonstrates that vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), an endothelial cell-selective cytokine, inhibits apoptosis of HDMEC cultured on untreated polystyrene and induces these cells to adhere, spread, and proliferate, VPF/VEGF-induced HDMEC adhesion was time-dependent, required de novo protein synthesis, and was inhibited by a soluble RGD peptide but not by an inhibitor of collagen synthesis. Under the conditions of these experiments, VPF/VEGF downregulated expression of collagen TV and fibronectin but did not change collagen I mRNA levels. VPF/VEGF-induced HDMEC adhesion was inhibited by antibodies to alpha v beta 5 and vitronectin but not by antibodies to alpha v beta 3. Other endothelial growth factors and cytokines such as bFGF, HGF, and TGF beta did not reproduce the VPF/VEGF effect. We suggest that VPF/VEGF induces endothelial cells to deposit a scaffolding (likely involving vitronectin) that allows them to attach to and proliferate on an otherwise nonsupportive surface (hydrophobic polystyrene) and in this manner serves as both a survival factor and a growth factor. (C) 1997 Academic Press.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 47 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[2]   APOPTOSIS OF VASCULAR ENDOTHELIAL-CELLS BY FIBROBLAST GROWTH-FACTOR DEPRIVATION [J].
ARAKI, S ;
SHIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1194-1200
[3]   HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS SYNTHESIZE S-PROTEIN (VITRONECTIN) INVITRO [J].
BERGE, V ;
JOHNSON, E ;
HOGASEN, K ;
HETLAND, G .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (01) :119-123
[4]   SUPPRESSION OF ICE AND APOPTOSIS IN MAMMARY EPITHELIAL-CELLS BY EXTRACELLULAR-MATRIX [J].
BOUDREAU, N ;
SYMPSON, CJ ;
WERB, Z ;
BISSELL, MJ .
SCIENCE, 1995, 267 (5199) :891-893
[5]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[6]   ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN [J].
BROOKS, PC ;
STROMBLAD, S ;
KLEMKE, R ;
VISSCHER, D ;
SARKAR, FH ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1815-1822
[7]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[8]  
BROWN LF, 1988, AM J PATHOL, V130, P455
[9]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[10]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I STABILIZES VITRONECTIN-DEPENDENT ADHESIONS IN HT-1080 CELLS [J].
CIAMBRONE, GJ ;
MCKEOWNLONGO, PJ .
JOURNAL OF CELL BIOLOGY, 1990, 111 (05) :2183-2195